Publication:
LUNGBANK: a novel biorepository strategy tailored for comprehensive multiomics analysis and P-medicine applications in lung cancer

Simple item page
dc.contributor.authorİbrahim Berkan AYDİLEK
dc.contributor.authorAli Sahin
dc.contributor.authoronur senol
dc.contributor.authorAbidin Sehitogullari
dc.contributor.authorsaban tekin
dc.contributor.authorAkif Turna
dc.contributor.authorMehmet Zeki Gunluoglu
dc.contributor.authorSerdar EVMAN
dc.contributor.authorVolkan Baysungur
dc.contributor.authorBetul Karademir
dc.contributor.authorAhmet Midi
dc.contributor.authorAsli Cakir
dc.contributor.authornur büyükpınarbaşılı
dc.contributor.authorİlker Kolbas
dc.contributor.authorUYGAR HALIS TAZEBAY
dc.contributor.authorDr. Hivda Ülbeği POLAT
dc.contributor.authorMAHMUT GÜMÜŞ
dc.contributor.authorİHSAN BOYACI
dc.contributor.authorKaan Ayberk Boyacıoğlu
dc.contributor.authorAbdullah Karadag
dc.contributor.authorMerve Oztug
dc.contributor.authorDilek Çeker
dc.contributor.authorAbdurrahim Gördebil
dc.contributor.authorsinem nalbantoglu
dc.contributor.authorYusuf TAMBAĞ
dc.contributor.authorOmer Kacar
dc.contributor.authorHatice Aslanoğlu
dc.contributor.authorNİLÜFER KARA
dc.contributor.authorNilgün ALĞAN
dc.contributor.authorALİ OSMAN ÇIBIKDİKEN
dc.contributor.authorMücahit Büyükyılmaz
dc.contributor.authorAbdulkerim Eneş
dc.contributor.authorSevde Küçüker
dc.contributor.authorFatih Karakaya
dc.contributor.authorEvren Saban
dc.contributor.authorOmer Soysal
dc.contributor.institutionHARRAN ÜNİVERSİTESİ
dc.contributor.institutionMARMARA ÜNİVERSİTESİ
dc.contributor.institutionATATÜRK ÜNİVERSİTESİ
dc.contributor.institutionSAKARYA ÜNİVERSİTESİ
dc.contributor.institutionSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
dc.contributor.institutionİSTANBUL ÜNİVERSİTESİ
dc.contributor.institutionİSTANBUL MEDİPOL ÜNİVERSİTESİ
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
dc.contributor.institutionMARMARA ÜNİVERSİTESİ
dc.contributor.institutionBAHÇEŞEHİR ÜNİVERSİTESİ
dc.contributor.institutionİSTANBUL MEDİPOL ÜNİVERSİTESİ
dc.contributor.institutionBEZMİÂLEM VAKIF ÜNİVERSİTESİ
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionGEBZE TEKNİK ÜNİVERSİTESİ
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionİSTANBUL MEDENİYET ÜNİVERSİTESİ
dc.contributor.institutionİSTANBUL MEDİPOL ÜNİVERSİTESİ
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionT.C. SAĞLIK BAKANLIĞI
dc.contributor.institutionKTO KARATAY ÜNİVERSİTESİ
dc.contributor.institutionÖzel Kuruluş
dc.contributor.institutionHARRAN ÜNİVERSİTESİ
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionTÜRKİYE BİLİMSEL ve TEKNOLOJİK ARAŞTIRMA KURUMU
dc.contributor.institutionBEZMİÂLEM VAKIF ÜNİVERSİTESİ
dc.date.accessioned2025-09-20T19:54:44Z
dc.date.issued2024
dc.date.submitted23.10.2024
dc.description.abstractBackground/aim: LUNGBANK was established as part of Project LUNGMARK, pioneering a biorepository dedicated exclusively to lung cancer research. It employs cutting-edge technologies to streamline the handling of biospecimens, ensuring the acquisition of high-quality samples. This infrastructure is fortified with robust data management capabilities, enabling seamless integration of diverse datasets. LUNGBANK functions not merely as a repository but as a sophisticated platform crucial for advancing lung cancer research, poised to facilitate significant discoveries. Materials and methods: LUNGBANK was meticulously designed to optimize every stage of biospecimen handling, from collection and storage to processing. Rigorous standard operating procedures and stringent quality control measures guarantee the integrity of collected biospecimens. Advanced data management protocols facilitate the efficient integration and analysis of various datasets, enhancing the depth and breadth of research possibilities in lung cancer. Results: LUNGBANK has amassed a comprehensive collection of biospecimens essential for unraveling the intricate molecular mechanisms of lung cancer. The integration of state-of-the-art technologies ensures the acquisition of top-tier data, fostering breakthroughs in translational and histological research. Moreover, the establishment of patient-derived systems by LUNGBANK underscores its pivotal role in personalized medicine approaches. Conclusion: The establishment of LUNGBANK marks a significant milestone in addressing the critical challenges of lung cancer research. By providing researchers with high-quality biospecimens and advanced research tools, LUNGBANK not only supports Project LUNGMARK’s objectives but also contributes extensively to the broader landscape of personalized medicine. It promises to enhance our understanding of lung cancer initiation, progression, and therapeutic interventions tailored to individual patient needs, thereby advancing the field towards more effective diagnostic and therapeutic strategies.
dc.identifier.doi10.55730/1300-0152.2696
dc.identifier.endpage217
dc.identifier.issn1300-0152
dc.identifier.issn1303-6092
dc.identifier.issue3
dc.identifier.startpage203
dc.identifier.urihttps://hdl.handle.net/20.500.14719/4419
dc.identifier.volume48
dc.language.isoen
dc.relation.journalTurkish Journal of Biology
dc.titleLUNGBANK: a novel biorepository strategy tailored for comprehensive multiomics analysis and P-medicine applications in lung cancer
dc.typeResearch Article
dcterms.referencesAnnaratone L, De Palma G, Bonizzi G, Sapino A, Botti G et al. (2021) Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Archiv: European Journal of Pathology 479: 233-246. https://doi.org/10.1007/ s00428-021-03151-0,Australasian Biospecimen Network,(2007). Guidelines for Biorepository Protocols.,Balarajah V, Ambily A, Dayem Ullah AZ, Imrali A, Dowe T et al. (2016) Pancreatic cancer tissue banks: Where are we heading? Future Medicine 12: 2661-2663. https://doi.org/10.2217/fon- 2016-0243,Ballantyne A (2019). Adjusting the focus: a public health ethics approach to data research. Bioethics 33: 357-366. https://doi. org/10.1111/bioe.12551,Bayat A (2002). Science, medicine, and the future: Bioinformatics. BMJ 324: 1018-1022. https://doi.org/10.1136/bmj.324.7344.1018,Bhardwaj A, Kishore S, Pandey DK (2022). Artificial Intelligence in Biological Sciences. Life 12 (9): 1430. https://doi.org/10.3390/ life12091430,Biswas N, Chakrabarti S (2020). Artificial intelligence (AI)-based systems biology approaches in multi-omics data analysis of cancer. Frontiers in Oncology 10: 588221. https://doi. org/10.3389/fonc.2020.588221,Bondy J (2014). Clinical annotation and data management in biorepositories. In: McManus LM, Mitchell RN (editors). Pathobiology of Human Disease. San Diego, USA: Academic Press, pp. 3035-3039. https://doi.org/10.1016/B978-0-12- 386456-7.06104-9,Botti G, Di Bonito M, Cantile M (2021). Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety. International Journal of Physiology, Pathophysiology and Pharmacology 13: 17-21.,Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarró LM et al. (2017) Human primary liver cancer– derived organoid cultures for disease modeling and drug screening. Nature Medicine 23: 1424-1435. https://doi. org/10.1038/nm.4438,Bruna A, Rueda OM, Greenwood W, Batra AS, Callari M et al. (2016) A biobank of breast cancer explants with preserved intra-tumor heterogeneity to screen anticancer compounds. Cell 167: 260-274. e222. https://doi.org/10.1016/j. cell.2016.08.041,Cai L, Xiao G, Gerber D, Minna J, Xie Y (2021). Lung cancer computational biology and resources. Cold Spring Harbor Perspectives in Medicine 12: a038273. https://doi.org/10.1101/ cshperspect.a038273,Calandrini C, Schutgens F, Oka R, Margaritis T, Candelli T et al. (2020) An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nature Communications 11: 1310. https://doi.org/10.1038/s41467- 020-15155-6,Carey DJ, Fetterolf SN, Davis FD, Faucett WA, Kirchner HL et al. (2016) The Geisinger MyCode community health initiative: an electronic health record–linked biobank for precision medicine research. Genetics in Medicine 18: 906-913. https://doi. org/10.1038/gim.2015.187,Chattopadhyay A, Lu TP (2019). Gene-gene interaction: the curse of dimensionality. Annals of Translational Medicine 7 (24): 813. https://doi.org/10.21037/atm.2019.12.87,Chen C, Wang J, Pan D, Wang X, Xu Y et al. (2023) Applications of multi-omics analysis in human diseases. MedComm 4: e315. https://doi.org/10.1002/mco2.315,Cibikdiken AO, Buyukyilmaz M, Nacar MA, Topcu AE, Tambag Y et al. (2018) Development of a new platform through distributed storage system for the bioinformatics analysis. DEStech Transactions Computer Science and Engineering https://doi. org/10.12783/dtcse/aiie2017/18233,Coppola L, Cianflone A, Grimaldi AM, Incoronato M, Bevilacqua P et al. (2019). Biobanking in health care: evolution and future directions. Journal of Translational Medicine 2019, 17: 1-18. https://doi.org/10.1186/s12967-019-1922-3,Day JG, Stacey GN (2008). Biobanking. Molecular Biotechnology 40: 202-213. https://doi.org/10.1007/s12033-008-9099-7,Dhai A (2016). The WMA declaration of Taipei: human databases and biobanks for the common good. South African Journal of Bioethics and Law 9: 50-51.,Gambardella V, Tarazona N, Cejalvo JM, Lombardi P, Huerta M et al. (2020) Personalized medicine: recent progress in cancer therapy. Cancers 12: 1009. https://doi.org/10.3390/cancers12041009,Goossens N, Nakagawa S, Sun X, Hoshida Y (2015). Cancer biomarker discovery and validation. Translational Cancer Research 4: 256- 269. https://doi.org/10.3978/j.issn.2218-676X.2015.06.04,Han SS, Kim WJ, Hong Y, Hong SH, Lee SJ et al. (2014) RNA sequencing identifies novel markers of non-small cell lung cancer. Lung Cancer 84: 229-235. https://doi.org/10.1016/j. lungcan.2014.03.018,Harati MD, Williams RR, Movassaghi M, Hojat A, Lucey GM et al. (2019) An Introduction to Starting a Biobank. In: Yong WH (ed) Biobanking: Methods and Protocols. Springer New York, New York, NY pp.7-16. https://doi.org/10.1007/978-1-4939-8935-5_2,Harris JR, Burton P, Knoppers BM, Lindpaintner K, Bledsoe M et al. (2012) Toward a roadmap in global biobanking for health. European Journal of Human Genetics 20: 1105-1111. https:// doi.org/10.1038/ejhg.2012.96,Horgan RP, Kenny LC (2011). ‘Omic’ technologies: genomics, transcriptomics, proteomics and metabolomics. The Obstetrician & Gynaecologist 13: 189-195. https://doi. org/10.1576/toag.13.3.189.27672,Ibarrola-Villava M, Cervantes A, Bardelli A (2018). Preclinical models for precision oncology. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1870: 239-246. https://doi. org/10.1016/j.bbcan.2018.06.004,Jimmy Juang JM, Liu YB, Julius Chen CY, Yu QY, Chattopadhyay A et al. (2020) Validation and disease risk assessment of previously reported genome-wide genetic variants associated with Brugada syndrome: SADS-TW BrS Registry. Circulation: Genomic and Precision Medicine 13: e002797. https://doi. org/10.1161/CIRCGEN.119.002797,Kalluri R, LeBleu VS (2020) The biology, function, and biomedical applications of exosomes. Science 367. https://doi.org/10.1126/ science.aau6977,Khan FH, Reza MJ, Shao YF, Perwez A, Zahra H et al. (2022) Role of exosomes in lung cancer: a comprehensive insight from immunomodulation to theragnostic applications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877: 188776. https://doi.org/10.1016/j.bbcan.2022.188776,Khoury MJ, Iademarco MF, Riley WT (2016) Precision public health for the era of precision medicine. American Journal of Preventive Medicine 50: 398-401. https://doi.org/10.1016/j. amepre.2015.08.031,Kim EY (2021) Biobanks as a Treasury for Precision Medicine. Healthcare Informatics Research 27: 93-94. https://doi. org/10.4258/hir.2021.27.2.93,Kim M, Mun H, Sung CO, Cho EJ, Jeon HJ et al. (2019a) Patient- derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nature Communications 10: 3991. https://doi.org/10.1038/s41467-019-11867-6,Kim SY, Lee JY, Kim DH, Joo HS, Yun MR et al. (2019b) Patient- derived cells to guide targeted therapy for advanced lung adenocarcinoma. Scientific Reports 9: 19909. https://doi. org/10.1038/s41598-019-56356-4,Kinkorová J (2016) Biobanks in the era of personalized medicine: objectives, challenges, and innovation: overview. EPMA Journal 7: 1-12. https://doi.org/10.1186/s13167-016-0053-7,Kinkorová J, Topolčan O (2020) Biobanks in the era of big data: objectives, challenges, perspectives, and innovations for predictive, preventive, and personalised medicine. The EPMA Journal 11: 333-341. https://doi.org/10.1007/s13167-020- 00213-2,Kita K, Fukuda K, Takahashi H, Tanimoto A, Nishiyama A et al. (2019) Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance. Cancer Science 110: 3215-3224. https://doi.org/10.1111/cas.14171,Lazareva TE, Barbitoff YA, Changalidis AI, Tkachenko AA, Maksiutenko EM et al. (2022) Biobanking as a tool for genomic research: from allele frequencies to cross-ancestry association studies. Journal of Personalized Medicine 12 (12): 2040. https:// doi.org/10.3390/jpm12122040,Lemjabbar-Alaoui H, Hassan OUI, Yang YW, Buchanan P (2015) Lung cancer: biology and treatment options. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1856: 189-210. https://doi.org/10.1016/j.bbcan.2015.08.002,Liu A, Pollard K (2015) Biobanking for personalized medicine. Advances in Experimental Medicine and Biology 864: 55-68. https://doi.org/10.1007/978-3-319-20579-3_5,Liu W, Cui Y, Zheng X, Yu K, Sun G (2023) Application status and future prospects of the PDX model in lung cancer. Frontiers in Oncology 13: 1098581. https://doi.org/10.3389/ fonc.2023.1098581,Lommen K, Odeh S, de Theije CC, Smits KM (2020) Biobanking in molecular biomarker research for the early detection of cancer. Cancers 12: 776. https://doi.org/10.3390/cancers12040776,Lu TP, Kamatani Y, Belbin G, Park T, Hsiao CK (2022) Current status and future challenges of biobank data analysis. Frontiers in Genetics 13: 882611. https://doi.org/10.3389/ fgene.2022.882611,Malsagova K, Kopylov A, Stepanov A, Butkova T, Sinitsyna A et al. (2020) Biobanks-a platform for scientific and biomedical research. Diagnostics 10 (7): 485. https://doi.org/10.3390/ diagnostics10070485,Mayrhofer MT, Holub P, Wutte A, Litton JE (2016) BBMRI-ERIC: the novel gateway to biobanks. Bundesgesundheitsblatt- Gesundheitsforschung-Gesundheitsschutz 379-384. https:// doi.org/10.1007/s00103-015-2301-8,Mohamadkhani A, Poustchi H (2015) Repository of human blood derivative biospecimens in biobank: technical implications. Middle East Journal of Digestive Diseases 7: 61.,Nalbantoglu S, Karadag A (2019) Introductory chapter: insight into the OMICS technologies and molecular medicine. Molecular Medicine 1: 1-10. https://doi.org/10.5772/intechopen.86450,Paskal W, Paskal AM, Dębski T, Gryziak M, Jaworowski J (2018). Aspects of modern biobank activity – comprehensive review. Pathology & Oncology Research 2018, 24: 771-785. https://doi. org/10.1007/s12253-018-0418-4,Patz EF, Caporaso NE, Dubinett SM, Massion PP, Hirsch FR et al. (2010) National lung cancer screening trial american college of radiology imaging network specimen biorepository originating from the contemporary screening for the detection of lung cancer trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. Journal of Thoracic Oncology 5: 1502-1506. https://doi.org/10.1097/JTO.0b013e3181f1c634,Pinker K, Chin J, Melsaether AN, Morris EA, Moy L (2018) Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment. Radiology 287: 732-747. https://doi.org/10.1148/radiol.2018172171,Poetsch A, Li Y (2023) Omics technologies and big data. In: Ning K (editor). Methodologies of Multi-Omics Data Integration and Data Mining: Techniques and Applications. Singapore: Springer Nature Singapore, pp. 33-54. https://doi.org/10.1007/978-981- 19-8210-1_3,Rao A, Vaught J, Guan P, Weil C, Moore HM (2017) The NCI best practices for biospecimen resources: 2016 revised recommendations. Cancer Research 2017, 77: 5947-5947. https://doi.org/10.1158/1538-7445.AM2017-5947,Riegman PH, Morente MM, Betsou F, De Blasio P, Geary P et al. (2008) Biobanking for better healthcare. Molecular Oncology 2: 213-222. https://doi.org/10.1016/j.molonc.2008.07.004,Rolfo C, Mack P, Scagliotti GV, Aggarwal C, Arcila ME et al. (2021) Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer. Journal of Thoracic Oncology 16: 1647-1662. https://doi. org/10.1016/j.jtho.2021.06.017,Rutten-Jacobs LC, Larsson SC, Malik R, Rannikmäe K, Sudlow CL et al. (2018) Genetic risk, incident stroke, and the benefits of adhering to a healthy lifestyle: cohort study of 306 473 UK Biobank participants. BMJ 363: k4168. https://doi.org/10.1136/ bmj.k4168,Sakaue S, Kanai M, Karjalainen J, Akiyama M, Kurki M et al. (2020) Trans-biobank analysis with 676,000 individuals elucidates the association of polygenic risk scores of complex traits with human lifespan. Nature Medicine 26: 542-548. https://doi. org/10.1038/s41591-020-0785-8,Schabath MB, Cote ML (2019) Cancer progress and priorities: lung cancer. Cancer Epidemiology, Biomarkers & Prevention 28: 1563-1579. https://doi.org/10.1158/1055-9965.EPI-19-0221,Schilsky RL (2010) Personalized medicine in oncology: the future is now. Nature Reviews Drug Discovery 9: 363-366. https://doi. org/10.1038/nrd3181,Sears CR, Mazzone PJ (2020) Biomarkers in lung cancer. Clinics in Chest Medicine 41: 115-127. https://doi.org/10.1016/j. ccm.2019.10.004,Sollini M, Bartoli F, Marciano A, Zanca R, Slart RH et al. (2020) Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology. European Journal of Hybrid Imaging 4: 1-22. https://doi.org/10.1186/s41824-020- 00094-8,Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I et al. (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians 71: 209-249. https://doi.org/10.3322/caac.21660,Tarkkala H, Helén I, Snell K (2019) From health to wealth: the future of personalized medicine in the making. Futures 109: 142-152. https://doi.org/10.1016/j.futures.2018.06.004,Toumazis I, Bastani M, Han SS, Plevritis SK (2020) Risk-based lung cancer screening: a systematic review. Lung Cancer 147: 154- 186. https://doi.org/10.1016/j.lungcan.2020.07.007,Troyer D (2008) Biorepository standards and protocols for collecting, processing, and storing human tissues. Tissue Proteomics 441: 193-220. https://doi.org/10.1007/978-1-60327-047-2_13,Vaught JB, Henderson MK (2011) Biological sample collection, processing, storage and information management. IARC Sci Publ 163: 23-42.,Washetine K, Heeke S, Bonnetaud C, Kara-Borni M, Ilié M et al. (2018) Establishing a dedicated lung cancer biobank at the University Center Hospital of Nice (France). Why and how? Cancers 10 (7): 220. https://doi.org/10.3390/cancers10070220,World Medical Association (2013). World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310: 2191-2194. https://doi. org/10.1001/jama.2013.281053,Yin L, Liu X, Shao X, Feng T, Xu J et al. (2021) The role of exosomes in lung cancer metastasis and clinical applications: an updated review. Journal of Translational Medicine 19: 312. https://doi. org/10.1186/s12967-021-02985-1,Yu K, Zhang J, Li X, Xu L, Zhang Y et al. (2015). Establishment and management of a lung cancer biobank in Eastern China. Thoracic cancer 6:58-63. https://doi.org/10.1111/1759- 7714.12144,Yu N, Hwang M, Lee Y, Song BR, Kang EH et al. (2023). Patient- derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer. Journal of Experimental & Clinical Cancer Research : CR 42:37. https://doi.org/10.1186/s13046- 023-02606-3
dspace.entity.typePublication
local.indexed.atTRDizin

Files

Collections

TR-Dizin İndeksli Yayınlar Koleksiyonu